Elevance Health (NYSE:ELV) shares fell on Thursday after the company's executive said it does not expect improvements in its operational Medicaid margins for the second half of the year.
At the Wells Fargo Healthcare conference, an executive of the company reflected on the challenging environment in the market, and said that its operating margin performance is expected to be softer than the outlook that provided in July.
The company, through a filing, also said it expects to reaffirm earnings guidance for full year 2025 at about $24.10 per share, including $5.90 per share of net unfavorable items.
Elevance also expects to reaffirm 2025 benefit expense ratio guidance of about 90%.
The shares of the company are down about 4%. Peers Centene (CNC) and Molina Healthcare (MOH) are also down about 5% today.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.